JP Morgan Chase & Co’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.7M | Sell |
|
|||||
|
2025
Q2 | $12.7M | Sell |
|
|||||
|
2025
Q1 | $39.9M | Sell |
|
|||||
|
2024
Q4 | $68M | Sell |
|
|||||
|
2024
Q3 | $138M | Sell |
|
|||||
|
2024
Q2 | $148M | Sell |
|
|||||
|
2024
Q1 | $185M | Sell |
|
|||||
|
2023
Q4 | $253M | Buy |
|
|||||
|
2023
Q3 | $158M | Sell |
|
|||||
|
2023
Q2 | $169M | Sell |
|
|||||
|
2023
Q1 | $152M | Buy |
|
|||||
|
2022
Q4 | $165M | Sell |
|
|||||
|
2022
Q3 | $150M | Sell |
|
|||||
|
2022
Q2 | $170M | Buy |
|
|||||
|
2022
Q1 | $147M | Buy |
|
|||||
|
2021
Q4 | $177M | Buy |
|
|||||
|
2021
Q3 | $146M | Buy |
|
|||||
|
2021
Q2 | $128M | Buy |
|
|||||
|
2021
Q1 | $117M | Buy |
|
|||||
|
2020
Q4 | $195M | Buy |
|
|||||
|
2020
Q3 | $117M | Buy |
|
|||||
|
2020
Q2 | $121M | Buy |
|
|||||
|
2020
Q1 | $61.6M | Buy |
|
|||||
|
2019
Q4 | $38M | Buy |
|
|||||
|
2019
Q3 | $7.27M | Buy |
|
|||||
|
2019
Q2 | $10.3M | Sell |
|
|||||
|
2019
Q1 | $12M | Sell |
|
|||||
|
2018
Q4 | $8.58M | Sell |
|
|||||
|
2018
Q3 | $11.8M | Buy |
|
|||||
|
2018
Q2 | $14.5M | Sell |
|
|||||
|
2018
Q1 | $14.8M | Sell |
|
|||||
|
2017
Q4 | $14.3M | Sell |
|
|||||
|
2017
Q3 | $18.6M | Sell |
|
|||||
|
2017
Q2 | $12.9M | Sell |
|
|||||
|
2017
Q1 | $10.5M | Buy |
|
|||||
|
2016
Q4 | $7.06M | Buy |
|
|||||
|
2016
Q3 | $3.36M | Sell |
|
|||||
|
2016
Q2 | $5.42M | Sell |
|
|||||
|
2016
Q1 | $9.62M | Buy |
|
|||||
|
2015
Q4 | $8.87M | Buy |
|
|||||
|
2015
Q3 | $6.06M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $2.76M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $634K | Buy |
|